PRICE T ROWE ASSOCIATES INC /MD/ - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 24 filers reported holding APTEVO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16
-76.5%
46,2000.0%0.00%
Q2 2023$68
-28.4%
46,2000.0%0.00%
Q1 2023$95
-11.2%
46,2000.0%0.00%
Q4 2022$107
-99.9%
46,2000.0%0.00%
Q3 2022$141,000
-14.5%
46,2000.0%0.00%
Q2 2022$165,000
-39.1%
46,2000.0%0.00%
Q1 2022$271,000
-25.5%
46,2000.0%0.00%
Q4 2021$364,000
+57.6%
46,200
+633.3%
0.00%
Q4 2020$231,0006,3000.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,760,000$39,477,0007.86%
RTW INVESTMENTS, LP 281,402$6,312,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 187,995$4,217,0000.09%
Anson Funds Management LP 35,587$798,0000.08%
Alyeska Investment Group, L.P. 139,172$3,122,0000.04%
Dynamic Technology Lab Private Ltd 14,022$315,0000.03%
JBF Capital, Inc. 3,907$88,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 15,350$344,0000.01%
Renaissance Technologies 159,923$3,587,0000.00%
QS Investors, LLC 15,650$352,0000.00%
View complete list of APTEVO THERAPEUTICS INC shareholders